- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x RET: RETINAL(Covalent)
- 18 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.3: 9 residues within 4Å:- Chain A: G.210, R.213, V.214, F.217, L.221, I.225, F.228, I.270, G.275
Ligand excluded by PLIPOLC.4: 5 residues within 4Å:- Chain A: I.215, F.216, M.219
- Chain B: I.131
- Ligands: OLC.21
Ligand excluded by PLIPOLC.5: 4 residues within 4Å:- Chain A: A.86, L.89, A.90, I.93
Ligand excluded by PLIPOLC.6: 7 residues within 4Å:- Chain A: K.186, V.193, Y.223, Y.226
- Chain B: W.120, Y.124
- Ligands: OLC.21
Ligand excluded by PLIPOLC.7: 9 residues within 4Å:- Chain A: T.204, Y.211, V.212, F.216
- Chain B: I.135, H.139, E.143, P.144, L.158
Ligand excluded by PLIPOLC.8: 5 residues within 4Å:- Chain A: A.232, I.236, Y.239, H.240
- Ligands: OLC.11
Ligand excluded by PLIPOLC.9: 3 residues within 4Å:- Chain A: F.228, F.229, A.232
Ligand excluded by PLIPOLC.10: 4 residues within 4Å:- Chain A: T.127, I.131
- Ligands: OLC.15, OLC.17
Ligand excluded by PLIPOLC.11: 4 residues within 4Å:- Chain A: T.252, W.256, F.259
- Ligands: OLC.8
Ligand excluded by PLIPOLC.14: 9 residues within 4Å:- Chain B: G.210, R.213, V.214, F.217, L.221, I.225, F.228, I.270, G.275
Ligand excluded by PLIPOLC.15: 5 residues within 4Å:- Chain A: I.131
- Chain B: I.215, F.216, M.219
- Ligands: OLC.10
Ligand excluded by PLIPOLC.16: 4 residues within 4Å:- Chain B: A.86, L.89, A.90, I.93
Ligand excluded by PLIPOLC.17: 7 residues within 4Å:- Chain A: W.120, Y.124
- Chain B: K.186, V.193, Y.223, Y.226
- Ligands: OLC.10
Ligand excluded by PLIPOLC.18: 9 residues within 4Å:- Chain A: I.135, H.139, E.143, P.144, L.158
- Chain B: T.204, Y.211, V.212, F.216
Ligand excluded by PLIPOLC.19: 5 residues within 4Å:- Chain B: A.232, I.236, Y.239, H.240
- Ligands: OLC.22
Ligand excluded by PLIPOLC.20: 3 residues within 4Å:- Chain B: F.228, F.229, A.232
Ligand excluded by PLIPOLC.21: 4 residues within 4Å:- Chain B: T.127, I.131
- Ligands: OLC.4, OLC.6
Ligand excluded by PLIPOLC.22: 4 residues within 4Å:- Chain B: T.252, W.256, F.259
- Ligands: OLC.19
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Oda, K. et al., Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin. Elife (2021)
- Release Date
- 2021-04-07
- Peptides
- Archaeal-type opsin 1,Archaeal-type opsin 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x RET: RETINAL(Covalent)
- 18 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Oda, K. et al., Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin. Elife (2021)
- Release Date
- 2021-04-07
- Peptides
- Archaeal-type opsin 1,Archaeal-type opsin 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A - Membrane
-
We predict this structure to be a membrane protein.